To the Editor: BCG is an effective vaccine to prevent tuberculosis (TB) in young children travelling to countries with a high prevalence of TB.1 Although it does not completely mitigate the risk of developing TB, nor the need for preventive therapy after a significant TB exposure, it provides about 80% protection against the severe forms of TB that affect infants and young children.2 In Australia, routine BCG vaccination ceased in 1985, and vaccination of children now effectively relies on the initiative of parents. A study in the United Kingdom reported that only 6% of parents were aware of national BCG vaccination recommendations.3 We aimed to determine the proportion of mothers from high-TB-prevalence countries giving birth in Australia who were planning to travel to these countries with their newborn child, and to assess their knowledge of the need to BCG-vaccinate their child.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
No relevant disclosures.